Holds 2 active US DMFs and 2 valid CEPs for ciclopirox, filing since 2002. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
EDQM certificate database
FDA, List of Drug Master Files
Holds 2 active US DMFs and 2 valid CEPs for ciclopirox, filing since 2002. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs and 2 valid CEPs for ciclopirox, filing since 1995. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
Holds one active US DMF for ciclopirox, filing since 2003. Its 2022 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one active US DMF for ciclopirox, filing since 2005. Its 2024 FDA inspection closed as VAI.
Holds 3 active US DMFs for ciclopirox, filing since 2025. Its 2025 FDA inspection closed as VAI.
Holds 2 valid CEPs for ciclopirox, filing since 2023. Its 2023 FDA inspection closed as NAI.
Holds 2 valid CEPs for ciclopirox, filing since 2021. Its 2021 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Registered with DAV (Vietnam) for ciclopirox. Its GMP is recognised in 1 market.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Contract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for ciclopirox and what filings they hold.
Chat with Fred, your AI analyst